Insiders · ATOS

Kyle Guse

Officer at Atossa Therapeutics, Inc. (ATOS)

Kyle Guse has filed 7 insider reports with the SEC since May 2021, as director at Cerenome, Inc. (CNSY) and officer at Atossa Therapeutics, Inc. (ATOS). The latest filing, on October 1, 2026, reports exercise or conversion of a derivative at Cerenome, Inc. (CNSY).

Filings
7
Companies
2
Bought on market
None
Sold on market
None

Companies where Kyle Guse is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cerenome, Inc. logo
CNSY
Cerenome, Inc.
Directorsince April 20251,843$0.7024Oct 1, 2026
Atossa Therapeutics, Inc. logo
ATOS
Atossa Therapeutics, Inc.
Officer$1.75Feb 28, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Kyle Guse with

Other insiders at the same companies

Questions about Kyle Guse

What is Kyle Guse's role at Atossa Therapeutics, Inc.?
Kyle Guse reports to the SEC as officer at Atossa Therapeutics, Inc. (ATOS), according to the latest filing on February 28, 2022. Kyle Guse has also filed as director at Cerenome, Inc. (CNSY).
How many shares does Kyle Guse own?
After the latest filing that states it, Kyle Guse directly owned 1,843 shares of Cerenome, Inc. (CNSY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Kyle Guse bought or sold stock recently?
No open-market purchases or sales by Kyle Guse are on file. The filings report exercise or conversion of a derivative and grant or award.
How do I get alerts when Kyle Guse files?
Follow Kyle Guse on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Kyle Guse filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Kyle Guse (SEC CIK 0001566618). Totals count each trade once, skipping amendments whose original is on file, from May 18, 2021 on. View on SEC EDGAR · Get this as JSON